Atlas Trials

Pharmacokinetics of Delafloxacin in Subjects With and Without Hepatic Impairment

Clinical trial NCT02245243 · COMPLETED

Trial details

NCT number
NCT02245243
Sponsor
Melinta Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2014-09-01
Primary completion
2015-02-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.